Browse by category

Zhejiang Doer Biologics completes enrolment of the Phase 1b/2a trial evaluating DR10624 in people with obesity with modest hypertriglyceridemia

Zhejiang Doer Biologics has completed the enrolment in the Phase 1b/2a trial evaluating DR10624 in people with obesity with modest...

First subject receives DR10624 for the treatment of obesity and hypertriglyceridemia

Zhejiang Doer Biologics, a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and...

Gastric pouch resizing for recurrent weight gain promotes weight stabilisation in well-selected patients

4 days ago

COVID-19 pandemic: Bariatric surgery patients showed an increase in the percentage of weight regain

4 days ago

Semaglutide and liraglutide may reduce alcohol consumption in individuals with AUD

4 days ago

Weekly Digest